RecruitingNot ApplicableNCT06906588

Bilateral Robot-assisted Upper Extremity Rehabilitation on Motor Recovery in People With Subacute Stroke

Effects of Bilateral Upper Limb Robot-assisted Rehabilitation on Motor Recovery in Patients With Subacute Stroke: an Italian Multicenter Randomized Controlled Trial


Sponsor

IRCCS San Raffaele Roma

Enrollment

70 participants

Start Date

May 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to study the clinical effects of a robotic rehabilitation treatment through a bilateral exoskeleton (Bilateral Robot-Assisted Therapy-BRAT) during standard rehabilitation, on motor recovery, compared to conventional arm re-education in people suffering from stroke in the subacute phase. The main question it aims to answer is what the effectiveness of Bilateral Robot-Assisted Therapy (BRAT) is in rehabilitating the upper limb in individuals with subacute stroke compared to conventional rehabilitation treatment in terms of motor function improvement as measured by the Fugl-Meyer Assessment - Upper Limb (FMA-UL), motor domain. Researchers will compare two groups (Experimental Group - EG and Control Group - CG) to see if the BRAT is more effective than conventional rehabilitation treatment in terms of motor recovery. Participants will be randomly assigned to one of the two treatment groups (EG or CG) and will be clinically and instrumentally evaluated at baseline (T0) and at the end of treatment (T1). EG, in addition to the standard rehabilitation treatment, will perform a 45-minute session of BRAT per day through the Arm Light Exoskeleton Hybrid (Alex RS - Wearable Robotics) robotic system. The CG, in addition to the standard routine rehabilitation treatment, will follow a conventional rehabilitation of the upper limbs without the use of technological devices. Finally, a telephone follow-up is scheduled three months after the end of the treatment.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Both sexes;
  • Age >18 years;
  • Unilateral hemipyramidal syndrome as demonstrated by a brain CT or MRI;
  • Distance from acute event < 6 months;
  • Modified Ashworth Scale (MAS) of shoulder, elbow, and wrist <3;
  • Ability to understand and sign the informed consent for the study;
  • Ability to perform the study procedures.

Exclusion Criteria8

  • Unstable general clinical conditions;
  • Bilateral pyramidal hemisyndrome severe visual impairment;
  • Recent injection of Botulinum Toxin to the affected upper limb or planned for the duration of the study;
  • Interruption of treatment for 1 week or 5 consecutive sessions;
  • Inability to adhere to the exercise program due to poor compliance;
  • Presence of neurological pathologies superimposed on the stroke event, psychiatric complications or personality disorders;
  • Presence of osteoarticular and neuromuscular pathologies that may compromise the motor skills of the upper limb;
  • Participants who have not signed the informed consent to the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEExperimental

The experimental group (EG), in addition to the standard rehabilitation treatment, will perform one upper limb BRAT session per day through the Arm Light Exoskeleton Hybrid (Alex RS - Wearable Robotics) robotic system.. Each participant will perform a total of 16+/-3 treatment sessions with a frequency of 4 times a week for 4 consecutive weeks. During the first session, the device should be adjusted according to the patient's bilateral size and suspension angle. The selection of personalized exercises will be based on each patient's motor skills and the difficulty can be gradually increased during the treatment period. These modalities are shown to the patient with visual and motor feedback (force feedback). The duration of the single rehabilitation treatment is 45 minutes, of which 5 minutes are used for setting up the device, 10 minutes for assembly/disassembly, 10 minutes for unilateral treatment with the affected upper limb and 20 minutes for bilateral treatment.

OTHERControl

The control group (GC), in addition to the standard routine rehabilitation treatment, will follow 45 minutes of conventional rehabilitation of the upper limbs without the use of technological devices. Each participant will perform a total of 16+/-3 conventional upper limb treatment sessions with a frequency of 4 times a week for 4 weeks. The motor exercises will concern the rehabilitation of the upper limb and will be performed with a therapist who will personalize the treatment based on the clinical characteristics and needs of the patient. Specifically, the treatment of the upper limb will be characterized by motor exercises (shoulder, elbow, wrist and hand), coordination and manual dexterity. Each session will consist of passive, active-assisted and active exercises.


Locations(3)

San Raffaele Cassino

Cassino, Italy, Italy

IRCCS San Raffaele Roma

Rome, Italy, Italy

San Raffaele Sulmona

Sulmona, Italy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06906588


Related Trials